Engineering the gram-positive cell surface for construction of bacterial vaccine vectors.
about
Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.Biotechnological approaches to fight pathogens at mucosal sites.Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody.Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants.Expression of a functional single-chain variable-fragment antibody against complement receptor 1 in Streptococcus gordonii.Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria.Expression and immunogenicity of a recombinant diphtheria toxin fragment A in Streptococcus gordonii.Bacterial SLH domain proteins are non-covalently anchored to the cell surface via a conserved mechanism involving wall polysaccharide pyruvylation.Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii.In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii.Integrative expression system for delivery of antibody fragments by lactobacilli.Display of heterologous proteins on the surface of Lactococcus lactis using the H and W domain of PrtB from Lactobacillus delburueckii subsp. bulgaricus as an anchoring matrix.Toll-like receptor 2-mediated modulation of growth and functions of regulatory T cells by oral streptococci.
P2860
Q34145098-AA0B18F0-C992-473D-B9D8-89FB05A0DDBEQ34351883-A9A48312-DB56-4615-81D7-EEA464F477F0Q34552312-3D2870DE-0246-4D01-B533-CB6DF63CF1E8Q35042482-1F1A33E9-EFAF-436A-977A-1AB85F678948Q36746887-1BA9BE1B-9057-4CC7-957D-24BD8AC0B117Q36974497-37474D5B-5E8D-4BA4-A717-BCA5A7D7E2ACQ37044911-CA01C48F-5D96-4989-B3E1-CEB61E6441F0Q38308679-6AF0AA26-9F6A-4959-B826-9A03AB1D332AQ40234321-CBE1F96B-FE94-4AFA-9307-D06E6DEEF549Q42581247-E0533AB9-19F1-4665-A423-0D724581358EQ42706463-587AD0A3-1D19-406B-A753-70D7BC491AFCQ47890345-F1D8D932-8F91-4C2F-AEA8-F48FC5044568Q53120011-1E00AA3F-122E-4DE0-9EF6-0269A0C02834
P2860
Engineering the gram-positive cell surface for construction of bacterial vaccine vectors.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Engineering the gram-positive cell surface for construction of bacterial vaccine vectors.
@ast
Engineering the gram-positive cell surface for construction of bacterial vaccine vectors.
@en
type
label
Engineering the gram-positive cell surface for construction of bacterial vaccine vectors.
@ast
Engineering the gram-positive cell surface for construction of bacterial vaccine vectors.
@en
prefLabel
Engineering the gram-positive cell surface for construction of bacterial vaccine vectors.
@ast
Engineering the gram-positive cell surface for construction of bacterial vaccine vectors.
@en
P50
P356
P1433
P1476
Engineering the gram-positive cell surface for construction of bacterial vaccine vectors
@en
P2093
P304
P356
10.1006/METH.1999.0842
P577
1999-09-01T00:00:00Z